Senestech (NASDAQ:SNES – Get Free Report) is anticipated to post its Q4 2025 results before the market opens on Wednesday, March 11th. Analysts expect Senestech to post earnings of ($0.30) per share and revenue of $0.7760 million for the quarter. Investors may visit the the company’s upcoming Q4 2025 earning results page for the latest details on the call scheduled for Thursday, March 12, 2026 at 4:00 PM ET.
Senestech Trading Up 2.8%
Shares of NASDAQ SNES opened at $2.19 on Wednesday. The stock has a market cap of $11.43 million, a P/E ratio of -0.60 and a beta of 0.15. The company has a debt-to-equity ratio of 0.01, a current ratio of 15.75 and a quick ratio of 14.73. Senestech has a 1 year low of $1.30 and a 1 year high of $6.24. The firm has a 50-day moving average of $2.10 and a 200 day moving average of $3.16.
Insider Buying and Selling at Senestech
In other news, major shareholder Glenbrook Capital Management acquired 34,613 shares of the firm’s stock in a transaction that occurred on Thursday, February 19th. The stock was bought at an average cost of $2.40 per share, for a total transaction of $83,071.20. Following the acquisition, the insider directly owned 704,211 shares in the company, valued at approximately $1,690,106.40. The trade was a 5.17% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link. Insiders have purchased a total of 173,954 shares of company stock worth $367,303 over the last ninety days. 5.29% of the stock is owned by company insiders.
Institutional Inflows and Outflows
Analyst Upgrades and Downgrades
Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Senestech in a research note on Monday, December 29th. One equities research analyst has rated the stock with a Strong Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, Senestech presently has an average rating of “Hold”.
Get Our Latest Research Report on SNES
Senestech Company Profile
SenesTech, Inc (NASDAQ: SNES) is a biotechnology company specializing in non-lethal pest management solutions. The company’s core focus is the development and commercialization of fertility-based control methods for commensal rodents, providing an alternative to traditional rodenticides. By targeting the reproductive cycle of rats, SenesTech aims to reduce rodent populations over time without the use of toxic chemicals, offering a more sustainable approach for pest management professionals.
The company’s flagship product, ContraPest®, is an EPA-registered liquid bait that disrupts rodent reproduction.
Featured Stories
- Five stocks we like better than Senestech
- New Copper-Rich “Kraken” Zone Discovered
- America’s 1776 happening again
- 3 Signs You May Want to Switch Financial Advisors
- Trade this between 9:30 and 10:45 am EST
- Silver’s squeeze is tightening – opportunity forming
Receive News & Ratings for Senestech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senestech and related companies with MarketBeat.com's FREE daily email newsletter.
